Neurocrine Biosciences reported $22.5M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
ALKERMES ALKS:US $ -28.99M 31.35M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amgen AMGN:US $ 1884M 1420M
Aptinyx Inc APTX:US $ -21231000 1.41M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Cytokinetics CYTK:US $ -76.09M 14.53M
Exelixis EXEL:US $ 38.2M 57.89M
Gilead Sciences GILD:US $ 2592M 1070M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Pfizer PFE:US $ 8146M 2582M
Prothena PRTA:US $ 109.25M 81.6M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Repligen RGEN:US $ 33.5M 2.74M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Teva Pharmaceutical TEVA:IT 290M 83M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
Xoma XOMA:US $ -4436000 2.2M
YTE INCY:US $ 181.74M 32.28M
Zogenix ZGNX:US $ -58M 0.89M